Unlock Cell Therapy Potential with Customizable Cell Isolation and Enhanced T cell Activation Solution

Cell isolation and activation are critical for cell therapy development and manufacturing. Ease of use, regulatory compliant and financial sustainability are among the most important considerations. Current options are hard to meet all the requirements and put limitation on cell therapy development.

In this webinar, we’ll introduce how GenScript’s Cytosinct™ Cell Isolation Nanobeads Customization Service and Enceed™ T Cell Activation Reagent empower researchers and developers to achieve optimal performance across diverse therapeutic workflows.

The Cytosinct™ customizable nanobead platform offers tailored solutions for isolating specific immune cell subsets with high purity and viability, while supporting various magnetic separation systems. Through surface marker flexibility and scalable production, GenScript enables seamless integration into both research and GMP-compliant processes.

Complementing this, the Enceed™ T Cell Activation Reagent provides a robust and reproducible way to activate and expand T cells — delivering strong activation signals with minimal variability to support downstream applications such as CAR-T manufacturing and immunological research. 

Join our experts to explore how these innovative tools can help enhance yield, consistency, and customization in your cell therapy development pipeline.

Learning Objectives: 

1. Explore strategies to tailor cell isolation workflows using Cytosinct™ customization options to meet unique research or manufacturing needs.

2. Evaluate performance benefits of Enceed™ T Cell Activation Reagent in promoting consistent and potent T cell activation for therapeutic development.